Novavax, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $65.3M | $1.57B |
| Jun 2022 | — | $-417.0M | $1.38B |
| Sep 2022 | — | $-566.0M | $1.28B |
| Dec 2022 | — | $-634.1M | $1.34B |
| Mar 2023 | — | $-895.6M | $625.0M |
| Jun 2023 | — | $-754.5M | $505.9M |
| Sep 2023 | — | $-678.4M | $651.1M |
| Dec 2023 | — | $-716.9M | $568.5M |
| Mar 2024 | — | $-867.1M | $480.6M |
| Jun 2024 | — | $-431.7M | $680.2M |
| Sep 2024 | — | $-526.4M | $573.6M |
| Dec 2024 | — | $-623.8M | $530.2M |
| Mar 2025 | — | $-75.6M | $263.3M |
| Jun 2025 | — | $37.6M | $253.7M |
| Sep 2025 | — | $-156.7M | $268.0M |
| Dec 2025 | $244.2M | $-127.8M | $240.6M |
| Mar 2026 | $291.0M | $-144.8M | $228.4M |
| Jun 2026 | $291.5M | $-190.7M | $191.5M |